Our team successfully filed three Biologics License Applications in the final months of the year and reduced our costs by 27 percent compared to 2023,” said Stephane Bancel, CEO of Moderna (MRNA).
After tough year, Moderna CEO confronts challenges for RSV, COVID businesses in shareholder letter Moderna developed its own generative AI application called mChat and rolled it out company-wide.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback